DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature

DPP-4 inhibitors for treating T2DM - hype or hope? an analysis based on the current literature

DPP-4 inhibition is an interesting line of therapy for treating Type 2 Diabetes Mellitus (T2DM) and is based on promoting the incretin effect. Here, the authors have presented a brief appraisal of DPP-4 inhibitors, their modes of action, and the clinical efficiency of currently available drugs based...

Full description

Bibliographic Details
Main Authors: Kunika Saini, Smriti Sharma, Yousuf Khan
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Molecular Biosciences
Subjects:
T2DM
incretin effect
DPP-4 enzyme
DPP-4 inhibitors
(GLP)-1
insulin
Online Access:https://www.frontiersin.org/articles/10.3389/fmolb.2023.1130625/full

Similar Items

Similar Items